CRISPR Trial Provides Hope for Inherited Blindness
A recent clinical trial, BRILLIANCE demonstrated the safety and efficacy of CRISPR gene editing in treating inherited blindness caused by mutations in the CEP290 gene.
Stay updated with breaking news from Bascom Palmer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A recent clinical trial, BRILLIANCE demonstrated the safety and efficacy of CRISPR gene editing in treating inherited blindness caused by mutations in the CEP290 gene.
BRILLIANCE trial results showed 11 out of 14 treated participants experienced some improvements in vision and quality of life measures. CRISPR-based therapy
Future studies must ensure the approach is safe, without serious side effects, expert says
MIAMI, Aug. 1, 2023 /PRNewswire/ -- Bascom Palmer Eye Institute of the University of Miami Health System has been ranked again as the nation's bes...